Agilent to buy pathology software maker Proscia for $240 million
Dollar banknotes are seen in this picture illustration taken June 13, 2017. REUTERS/Dado Ruvic/Illustration
Read a summary of this article on FAST.
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST
Oct 13 : Agilent Technologies said on Tuesday it would acquire pathology software maker Proscia for $240 million in cash, plus up to $30 million tied to future performance targets, as the laboratory equipment maker expands its push into AI-enabled diagnostics.
Here are some more details:
• Privately held Proscia develops software that converts pathology slides into digital images that can be stored, reviewed and analyzed using artificial intelligence tools
• Agilent said the acquisition would strengthen its pathology business and expand its presence in digital and AI-enabled diagnostics
![]()
Guess Word
Crack the word, one row at a time
![]()
Buzzword
Create words using the given letters
![]()
Mini Sudoku
Tiny puzzle, mighty brain teaser
![]()
Mini Crossword
Small grid, big challenge
![]()
Word Search
Spot as many words as you can
• The deal would provide Agilent access to a high-growth software business that generated more than $18 million in revenue over the past 12 months
• The companies have worked together since 2022, when they entered a multi-year distribution agreement to offer a digital pathology system combining Agilent’s pathology products with Proscia’s software
• The deal is expected to close early in Agilent’s fiscal 2027
Source: Reuters
Sign up for our newsletters

Get the CNA app
Stay updated with notifications for breaking news and our best stories
Get WhatsApp alerts
Join our channel for the top reads for the day on your preferred chat app

Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST
Tap here to return to FAST
FAST














